Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin + pioglitazone in type 2 diabetes
NCT01026194Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Dec 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by Mitsubishi Tanabe Pharma. Started Dec 2009; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01026194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026194.